Arun Sridhar

Founder/Director, Stealth Bioelectronic Medicine Initiative

An accomplished scientist with numerous publications and patent inventorship on over 40 patent applications and a clinical cardiology and translational research experience, Arun Sridhar established the first Bioelectronic Medicines R&D unit at GSK, before it garnering a $715 million investment to form Galvani Bioelectronics.

He has experience in taking ideas from back of a napkin to the clinic, and now is currently working on his stealth bioelectronic medicine initiative.

Arun Sridhar